Leading Executives in Medical Equipment
Geoff Martha
Chairman & CEO, Medtronic
Opened Medtronic’s ventilator IP during COVID-19 to boost global access and is pushing robotics (Hugo) and AI across the portfolio as Chairman & CEO (since 2020).
Company Bio | LinkedIn | X (Twitter)
Peter J. Arduini
President & CEO, GE HealthCare
Led GE HealthCare’s transition to an independent, publicly traded company focused on precision care (Nasdaq: GEHC, Jan 4, 2023) and continues to drive growth as President & CEO.
Company Bio | LinkedIn | Company X
Robert B. Ford
Chairman & CEO, Abbott
Chairs and leads Abbott after decades building its Medical Devices businesses; oversaw the expansion of glucose monitoring and other device franchises since becoming CEO in 2020 and Chair in 2021.
Company Bio | Company LinkedIn | Company X
Dr. Bernd Montag
Chief Executive Officer, Siemens Healthineers
A decade-long CEO who led Healthineers’ 2018 IPO, DAX inclusion, and the $16.4B Varian acquisition to expand into cancer care.
Company Bio | Company LinkedIn | Company X
Michael (Mike) F. Mahoney
Chairman & CEO, Boston Scientific
Engineered a high-profile turnaround since 2012, more than doubling revenue and building a prolific M&A and innovation engine across structural heart, electrophysiology and more.
Company Bio | Company LinkedIn | Company X
Kevin A. Lobo
Chair & CEO, Stryker
Long-tenured chief who has guided Stryker through aggressive, strategy-led expansion—completing 60+ acquisitions—while scaling orthopaedics and MedSurg leadership.
Company Bio | Company LinkedIn | Company X
Roy Jakobs
Chief Executive Officer, Philips
Appointed CEO in October 2022, he is steering Philips’ health-tech focus and the operational/quality turnaround following the Respironics recall.
Company Bio | Company LinkedIn | Company X
Tom Polen
Chairman, CEO & President, BD (Becton, Dickinson and Company)
Chairman & CEO who set BD’s 2025 strategy (Grow, Simplify, Empower) and previously led integration of CareFusion and strategy for the Bard acquisition to expand BD’s medtech reach.
Company Bio | LinkedIn | Company X
Brent Shafer
Chair & Interim CEO, Baxter
Former Cerner chief Brent Shafer became Baxter’s Chair and Interim CEO on Feb 3, 2025, to guide the company’s next chapter following the Vantive separation and CEO transition.
Company Release | Company LinkedIn
Ivan Tornos
Chairman, President & CEO, Zimmer Biomet
Became President & CEO in 2023 and was named Chairman in May 2025; now leading ZB’s orthopaedics portfolio with a focus on innovation and execution.
Company Bio | Company LinkedIn | Company X
Bernard J. Zovighian
Chief Executive Officer, Edwards Lifesciences
CEO since 2023, he sharpened Edwards’ focus on structural heart therapy and executed the divestiture of the Critical Care unit to BD in 2024.
Company Bio | Company LinkedIn | Company X
Dave Rosa
Chief Executive Officer, Intuitive (Intuitive Surgical)
A 29-year Intuitive veteran who helped build the Ion endoluminal and da Vinci SP platforms, Dave became CEO on July 1, 2025 to lead the next phase of robotic-assisted surgery.
Company Release | Company LinkedIn | Company X
Stephen P. MacMillan
Chairman, President & CEO, Hologic
Chairman, President & CEO recognized for scaling Hologic’s leadership in women’s health across diagnostics, imaging and minimally invasive solutions.
Company Newsroom | Company LinkedIn
Hikaru Samejima
Chief Executive Officer, Terumo
As CEO of Japan’s global medtech leader, he is expanding Terumo’s innovation footprint—including a new U.S. Corporate R&D center (D-TECT) announced in March 2025.
Company Overview | Company LinkedIn
David J. Endicott
Chief Executive Officer, Alcon
Alcon’s CEO has driven the eye-care leader’s post-spin growth and pharma expansion through deals like Aerie Pharmaceuticals and a majority stake in Aurion Biotech.
Company Newsroom | Company LinkedIn
Michael “Mick” Farrell
Chairman & CEO, ResMed
CEO since 2013 and Chair since 2023, he has scaled ResMed’s cloud-connected sleep and respiratory care platform into a leading out-of-hospital digital health business.
Company Bio | Company LinkedIn | Company X
Deepak Nath
Chief Executive Officer, Smith+Nephew
CEO since 2022, he is executing on orthopaedics and sports medicine performance and has resisted break-up calls, emphasizing value creation within the current portfolio.
Company Bio | Company LinkedIn
Bryan C. Hanson
Chief Executive Officer, Solventum (spun off from 3M Health Care)
Former Zimmer Biomet CEO now leading 3M’s $8B+ Health Care spinout as an independent medtech company with 22,000 employees and a diversified portfolio.
Company Leadership | Company LinkedIn
Catherine (Katie) Szyman
Chief Executive Officer, Masimo
Appointed CEO effective Feb 12, 2025, the longtime medtech leader (ex-Edwards Critical Care and BD) is charting Masimo’s next phase in advanced patient monitoring.
Company Release | Company LinkedIn
Kevin R. Sayer
Chairman, President & CEO, Dexcom
Chairman, President & CEO who helped make CGM mainstream worldwide, scaling Dexcom’s sensor platform and access initiatives.
Company Bio | Company LinkedIn | Company X
Related Topics
Further Reading
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.